Algestone acetophenide

CAS : 24356-94-3

Ref. 3D-FA32126

Informations sur le produit

• Nom: Algestone acetophenide
• Synonymes: (16α)-16,17-[[(1R)-1-Phenylethylidene]bis(oxy)]pregn-4-ene-3,20-dione, (4aR,4bS,6aS,6bS,8R,9aR,10aS,10bR)-6b-acetyl-4a,6a,8-trimethyl-8-phenyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, (4bS,6bS,9aR,10aS)-6b-acetyl-4a,6a,8-trimethyl-8-phenyl-3,4,4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-tetradecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one, (R)-16alpha,17-((1-Phenylethylidene)dioxy)pregn-4-ene-3,20-dione, (R)-16alpha,17-Dihydroxypregn-4-ene-3,20-dione cyclic acetal with acetophenone, 16-alpha,17-Dihydroxypregn-4-ene-3,20-dione cyclic acetal with acetophenone, 16-alpha,17-alpha-Dihydroxyprogesterone acetophenide, 16alpha,17-((R)-1-Phenylethylidendioxy-4-pregnen-3,20-dion, 16alpha,17alpha-Dihydroxyprogesterone acetophenone, 2H-Naphth[1′,2′:6,7]indeno[1,2-d][1,3]dioxole, pregn-4-ene-3,20-dione deriv., Algesterone acetophenide, Algeston acetofenid, Algestoneacetophonide, Alphasone acetophenide, Deladroxone, Dihydroxyprogesterone acetophenide, Droxone, Neolutin, Neolutin Depositum, P-Dhp, Pregn-4-ene-3,20-dione, 16,17-((1-phenylethylidene)bis(oxy))-, (16alpha(R))-, Pregn-4-ene-3,20-dione, 16,17-[(1-phenylethylidene)bis(oxy)]-, [16α(R)]-, Pregn-4-ene-3,20-dione, 16,17-[[(1R)-1-phenylethylidene]bis(oxy)]-, (16α)-, Pregn-4-ene-3,20-dione, 16-alpha,17-dihydroxy-, cyclic acetal with acetophenone, (R)-, Pregn-4-ene-3,20-dione, 16α,17-dihydroxy-, cyclic acetal with acetophenone, (R)-, Sq 15101, Unii-Ol7Kc2O3Ot, Zk 9349

Description

Algestone acetophenide is a progestin that inhibits ovulation, which is the release of an egg from the ovary. It also prevents pregnancy by thickening cervical mucus and thinning the uterine lining. Algestone acetophenide is used in combination with estradiol benzoate as a contraceptive. Algestone acetophenide has been shown to have carcinogenic potential, specifically in fatty cells and in abdominal surgery patients. The compound has been shown to have physiological effects such as controlling blood pressure and regulating cholesterol levels. It also increases the risk of heart disease and stroke, especially in women who smoke or are over age 35.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 448.59 g/mol
• Formule: C₂₉H₃₆O₄
• Degré de pureté: Min. 95%